Evidence map›Paper›PMID 18590318›Full record

ArticleJournal of proteome research2008

How calmodulin interacts with the adenosine A(2A) and the dopamine D(2) receptors.

Amina S Woods, Daniel Marcellino, Shelley N Jackson, Rafael Franco, Sergi Ferré, Luigi F Agnati, Kjell Fuxe

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. FDA Drug Repurposing Uncovers Modulators of Dopamine DJournal of medicinal chemistry · 2025
    Article
  2. Tumor-Associated Glycan Exploits Adenosine Receptor 2A Signaling to Facilitate Immune Evasion.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Cathepsin D interacts with adenosine AThe Journal of biological chemistry · 2022
    Article
  4. Review
  5. Review
  6. Calcium Sensors in Neuronal Function and Dysfunction.Cold Spring Harbor perspectives in biology · 2019
    Review
  7. Histidine, the less interactive cousin of arginine.European journal of mass spectrometry (Chichester, England) · 2019
    Article
  8. Neuronal Calcium and cAMP Cross-Talk Mediated by Cannabinoid CBFrontiers in cell and developmental biology · 2018
    Article
  9. Article
  10. Article
  11. Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor field.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Review
  12. Imaging of noncovalent complexes by MALDI-MS.Journal of the American Society for Mass Spectrometry · 2013
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Triplet puzzle: homologies of receptor heteromers.Journal of molecular neuroscience : MN · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Amina S WoodsNational Institute on Drug Abuse, IRP, NIH, DHHS, Baltimore, MD 21224, USA. awoods@intra.nida.nih.gov
Daniel Marcellino
Shelley N Jackson
Rafael Franco
Sergi Ferré
Luigi F Agnati
Kjell Fuxe
Karolinska Institutet · SENational Institute on Drug Abuse · USUniversitat de Barcelona · ES

Funding

Neurotransmitter Receptor Heteromers in the Striatal Spine ModuleZ01DA000493 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI GOLDBERG, STEVEN R · 2006 to 2008
$691k
Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

Receptor heteromerization is a mechanism used by G protein-coupled receptors to diversify their properties and function. We previously demonstrated that these interactions occur through salt bridge formation between epitopes of the involved receptors. Recent studies claim that calmodulin (CaM) binds to an Arg-rich epitope located in the amino-terminus of the dopamine D(2) receptor third intracellular loop. This is the same epitope involved in adenosine A(2A)-D(2) receptor heteromerization, through Coulombic interaction between the Arg residues and a phosphorylated serine (pS) located in the medial segment of the C-terminus of the A(2A) receptor. Mass spectrometric analysis indicates that an electrostatic interaction involving the D(2) receptor Arg-rich epitope and several CaM acidic epitopes are mainly responsible for the D(2) receptor-CaM binding. CaM could also form multiple noncovalent complexes by means of electrostatic interactions with an epitope localized in the proximal segment of the C-terminus of the A(2A) receptor. Ca(2+) disrupted the binding of CaM to the D(2) but not to the A(2A) receptor epitope, and CaM disrupted the electrostatic interactions between the D(2) receptor epitope and the more distal A(2A) receptor epitope. A model is introduced with the possible functional implications of A(2A)-D(2)-CaM interactions. These in vitro findings imply a possible regulatory role for CaM in receptor heteromers formation.

Indexed as

Models, MolecularAmino Acid SequenceAnimalsBinding SitesCalmodulinCattleChymotrypsinMolecular Sequence DataPeptide FragmentsReceptor, Adenosine A2AReceptors, Dopamine D2Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStatic ElectricityCalmodulinChymotrypsinPeptide FragmentsReceptor, Adenosine A2AReceptors, Dopamine D2

Identifiers

PMID18590318
PMCPMC2538563
OpenAlexW2015191525

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.